What is INCY's current stock price?

INCY is currently trading at $100.04 with a daily change of -1.21%. Visit StocksRunner for live updates.

What are INCY stock's key strengths?

INCY current strengths include: Outperform the market, Earnings are forecast to grow, Trading below its fair value, Upgraded on attractively valued. These are updated in real time by the StocksRunner IQ algorithm.

What are the risks associated with INCY stock?

Current risk factors for INCY include: Low. Risk levels are assessed by StocksRunner based on volatility, sector strength, volume, and investor confidence.

What is INCY's current StocksRunner IQ Score?

INCY current StocksRunner IQ Score is: Buy. This score reflects aggregated earnings data, news sentiment, analyst ratings, and market momentum as of the latest update.

What factors influence INCY's StocksRunner IQ Score?

INCY StocksRunner IQ Score is a composite Credibility Score that weighs: quarterly earnings results vs. analyst expectations, breaking news sentiment and headline credibility, Wall Street analyst price target consensus, trading volume and price momentum, and sector-level risk indicators. All factors are aggregated in real time.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

INCY Stock Analysis & IQ Rating | Incyte Corp.

Q: Should I buy INCY stock right now?

StocksRunner does not provide personalized investment advice. Our IQ Credibility Score for INCY aggregates analyst sentiment, earnings performance, and news momentum to help you make an informed decision. The current IQ signal is: Buy. Always consider your own risk tolerance and consult a financial advisor before investing.

Q: What does a Strong Buy rating mean for INCY?

A Strong Buy rating on StocksRunner indicates that the aggregated IQ score — drawing from earnings beats, analyst upgrades, and positive news sentiment — reflects high confidence in INCY near-term growth potential. It is the strongest signal in the StocksRunner IQ rating scale.

INCY

Incyte Corp.

$100.04

-$1.23 | -1.21%

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$112.29

MKT CAP

$19.91B

52W Low

$53.56

VOL

$1.61M

P/E Ratio

N/A

AVG VOL

$1.87M

RSI

45.23

TREND

Sideways

INCY Stock IQ

Login to see Incyte Corp. (INCY) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

INCY Target Price

Login to display

Strengths

INCY Rewards

Earnings are forecast to grow

INCY Rewards

Upgraded on attractively valued

INCY Rewards

Outperform the market

INCY Rewards

Trading below its fair value

INCY Price Performance

$100.92 (-0.87%)

$100.46 (-0.42%)

$87.21 (+14.71%)

$60 (+66.73%)

1year

6month

3month

1month

INCY Analysts Opinion

Overall standing based on market and analyst consensus. menu Hover over the category for more information

INCY Analysts opinion is negative and it remained unchanged from the past 3 months

INCY Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

74%

Consensus Rating

100%

Buy
Opinion

0%

Trend
Score

83%

Potential
Score

INCY Street Sentiment is bullish and have positive views on the near-term outlook

INCY Risk Level

INCY has Low risk level

Risk Indicators

Investors losing confidence

Low

LOW

HIGH

INCY Performance Sentiment

Sentiments overview associated with events and the stock performance

74%

Positive

28 out of 38
events present

26%

Negative

10 out of 38
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price

$98.30

Resistance Price

$109.03

Current Price Range

$100.04

$98.30

$109.03

Show methods +

Analyst Consensus

Recent Upgrades and Downgrades

90%

Consensus Rating

STRONG BUY

9

Buy

1

Hold

0

Sell

Date

Action

Rating

Firm

Feb 06, 2026

Initiate

Buy

HC Wainwright & Co.

Feb 05, 2026

Upgrade

Buy

Benchmark

Dec 09, 2025

Reiterate

Overweight

Wells Fargo

Dec 09, 2025

Upgrade

Outperform

Mizuho

Nov 25, 2025

Reiterate

Overweight

Barclays

INCY Latest Analysis +

Incyte Corporation (INCY) Presents at TD Cowen 46th Annual Health Care Conference Transcript.

Today

$100.04 | -1.21%

Activity

Incyte Corp. (INCY) Reports Q4 2025 Revenue Growth of 28% to $1.51B Driven by Jakafi and Opzelura Sales. Incyte Corporation (NASDAQ:INCY) is one of the best NASDAQ growth stocks to buy for the next 2 years. On February 10 Incyte Corporation reported that the companys Q4 2025 revenue climbed 28% to $1.51 billion while full-year sales reached $5.14 billion. The companys growth was largely propelled by its flagship product Jakafi which achieved annual [….]

Fri Feb 20, 2026

$101.32 | -0.40%

Activity

Potential

Incytes weak Opzelura 2026 revenue forecast heightens Jakafi patent concerns (Feb 10).

Fri Feb 13, 2026

$101.10 | +0.35%

Activity

Incyte: Why The Market Is Overreacting To A Guidance Miss.

Wed Feb 11, 2026

$98.84 | -1.21%

Earnings

Incyte falls as Q4 results 2026 revenue guidance disappoint.

Tue Feb 10, 2026

$100.05 | -8.24%

Momentum

Potential

Incyte outlines 10–13% revenue growth for 2026 amid robust pipeline expansion and new product launches.

Tue Feb 10, 2026

$100.05 | -8.24%

Activity

Potential

INCY Q4 Earnings Miss Estimates Revenues Beat on Higher Product Sales. Incyte posts a Q4 EPS miss but a 28% revenue jump fueled by Jakafi and Opzelura strength as product sales top estimates.

Tue Feb 10, 2026

$100.05 | -8.24%

Earnings

Incyte Crumbles As Light Opzelura Guide Undoes Quarterly Sales Beat. Incyte stock crumbled Tuesday after lighter-than-expected guidance for 2026 Opzelura sales undercut its fourth-quarter revenue beat.The post Incyte Crumbles As Light Opzelura Guide Undoes Quarterly Sales Beat appeared first on Investor'.s Business Daily.

Tue Feb 10, 2026

$100.05 | -8.24%

Earnings

Momentum

Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Pipeline ... This article first appeared on GuruFocus.Release Date: February 10 2026For the complete transcript of the earnings call please refer to the full earnings call transcript.Positive Points-Incyte Corp (NASDAQ:INCY) exceeded expectations in total sales JACfi sales and core business sales

Tue Feb 10, 2026

$100.05 | -8.24%

Earnings

Incyte Corporation Q4 Profit Increases Beats Estimates . (RTTNews) - Incyte Corporation (INCY) announced earnings for its fourth quarter that Increased from last year and beat the Street estimates.

Tue Feb 10, 2026

$100.05 | -8.24%

Earnings

FAQ About INCY Stock Insights

What is INCY current stock price?

What are INCY stock strengths?

What is INCY Risk Level?

What is INCY market cap and volume?

What is INCY current Stock IQ?

Should I buy INCY stock right now?

Is INCY a Strong Buy right now?

What does a 'Strong Buy' rating mean for INCY?

What does a 'Strong Sell' rating mean for INCY?

What factors influence INCY's Stock IQ?

Explore our INCY Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored INCY Stock Strategies
Effective Risk Management

FIND US ON

Receive our INCY Daily Alerts

Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

INCY

Incyte Corp.

Set Alerts

Current Price

$100.04

-$1.23 | -1.21%

52W High

$112.29

MKT CAP

$19.91B

52W Low

$53.56

VOL

$1.61M

P/E Ratio

N/A

AVG VOL

$1.87M

RSI

45.23

TREND

Sideways

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

INCY Price Performance

$100.92 (-0.87%)

$100.46 (-0.42%)

$87.21 (+14.71%)

$60 (+66.73%)

1year

6month

3month

1month

INCY Analysts Opinion

Overall standing per market and analyst expectations. menu Hover over the category for more information

INCY Analysts opinion is negative and it remained unchanged from the past 3 months

INCY Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

74%

Consensus Rating

100%

Buy
Opinion

0%

Trend
Score

83%

Potential
Score

INCY Street Sentiment is bullish and have positive views on the near-term outlook

INCY Risk Level

INCY has Low risk level

Risk Indicators

Investors losing confidence

Low

LOW

HIGH

INCY Performance Sentiment

Sentiments overview associated with events and the stock performance.

74%

Positive

28 out of 38
events present

26%

Negative

10 out of 38
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price

$98.30

Resistance Price

$109.03

Current Price Range

$100.04

$98.30

$109.03

Show methods +

Latest Analyst Actions

Overall Wall Street Rating

90%

Consensus Rating

STRONG BUY

9

Buy

1

Hold

0

Sell

Date

Action

Rating

Firm

Feb 06, 2026

Initiate

Buy

HC Wainwright & Co.

Feb 05, 2026

Upgrade

Buy

Benchmark

Dec 09, 2025

Reiterate

Overweight

Wells Fargo

Dec 09, 2025

Upgrade

Outperform

Mizuho

Nov 25, 2025

Reiterate

Overweight

Barclays

INCY Stock IQ

Login to unlock Incyte Corp. (INCY) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Target Price

Login to display

Stock Insights

Strengths

INCY Rewards

Earnings are forecast to grow

INCY Rewards

Upgraded on attractively valued

INCY Rewards

Outperform the market

INCY Rewards

Trading below its fair value

INCY Latest Analysis

Incyte Corporation (INCY) Presents at TD Cowen 46th Annual Health Care Conference Transcript.

Today

$100.04 | -1.21%

Activity

Incyte Corp. (INCY) Reports Q4 2025 Revenue Growth of 28% to $1.51B Driven by Jakafi and Opzelura Sales. Incyte Corporation (NASDAQ:INCY) is one of the best NASDAQ growth stocks to buy for the next 2 years. On February 10 Incyte Corporation reported that the companys Q4 2025 revenue climbed 28% to $1.51 billion while full-year sales reached $5.14 billion. The companys growth was largely propelled by its flagship product Jakafi which achieved annual [….]

Fri Feb 20, 2026

$101.32 | -0.40%

Activity

Potential

Incytes weak Opzelura 2026 revenue forecast heightens Jakafi patent concerns (Feb 10).

Fri Feb 13, 2026

$101.10 | +0.35%

Activity

Incyte: Why The Market Is Overreacting To A Guidance Miss.

Wed Feb 11, 2026

$98.84 | -1.21%

Earnings

Incyte falls as Q4 results 2026 revenue guidance disappoint.

Tue Feb 10, 2026

$100.05 | -8.24%

Momentum

Potential

Incyte outlines 10–13% revenue growth for 2026 amid robust pipeline expansion and new product launches.

Tue Feb 10, 2026

$100.05 | -8.24%

Activity

Potential

INCY Q4 Earnings Miss Estimates Revenues Beat on Higher Product Sales. Incyte posts a Q4 EPS miss but a 28% revenue jump fueled by Jakafi and Opzelura strength as product sales top estimates.

Tue Feb 10, 2026

$100.05 | -8.24%

Earnings

Discover INCY Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of INCY. We're here to help you make informed investment decisions today.

FIND US ON

Receive our INCY Daily Alerts

Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

INCY Stock trends

INCY Stock performance

INCY Stock analysis

INCY investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing INCY

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing INCY

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

INCY Stock Analysis & IQ Rating | Incyte Corp.

INCY Stock IQ

INCY Target Price

INCY Analysts Opinion

INCY Street Sentiment

INCY Risk Level

INCY Performance Sentiment

Key Price Levels

Analyst Consensus

Explore our INCY Stock insights

Receive our INCY Daily Alerts

INCY Street Sentiment

INCY Risk Level

Key Price Levels

Latest Analyst Actions

Discover INCY Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of INCY. We're here to help you make informed investment decisions today.

Receive our INCY Daily Alerts

INCY Alerts